Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Delineation of antigen-specific and antigen-nonspecific CD8 + memory T-cell responses after cytokine-based cancer immunotherapy

Julia K. Tietze, Danice E. C. Wilkins, Gail D. Sckisel, Myriam N. Bouchlaka, Kory L. Alderson, Jonathan M. Weiss, Erik Ames, Kevin W. Bruhn, Noah Craft, Robert H. Wiltrout, Dan L. Longo, Lewis L. Lanier, Bruce R. Blazar, Doug Redelman, William J. Murphy

Blood (2012) 119 (13): 3073–3083.

https://doi.org/10.1182/blood-2011-07-369736

Published: 2012

Includes: Supplemental data

Journal Articles

Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing

Kai Sun, Maite Alvarez, Erik Ames, Isabel Barao, Mingyi Chen, Dan L. Longo, Doug Redelman, William J. Murphy

Blood (2012) 119 (6): 1590–1598.

https://doi.org/10.1182/blood-2011-08-374314

Published: 2012

Includes: Supplemental data

Journal Articles

Mouse Ly49G2 + NK cells dominate early responses during both immune reconstitution and activation independently of MHC

Isabel Barao, Maite Alvarez, Erik Ames, Mark T. Orr, Heather E. Stefanski, Bruce R. Blazar, Lewis L. Lanier, Stephen K. Anderson, Doug Redelman, William J. Murphy

Blood (2011) 117 (26): 7032–7041.

https://doi.org/10.1182/blood-2010-11-316653

Published: 2011

Includes: Supplemental data

Journal Articles

Natural Killer (NK) Cell Recovery After Bone Marrow Transplantation in Mice: Early Emergence of a Novel Ly49+ Stage in Differentiation Independent of MHC Haplotype.

William Murphy, PhD, Doug Redelman, PhD, Isabel Barao, PhD

Blood (2009) 114 (22): 4477.

https://doi.org/10.1182/blood.V114.22.4477.4477

Published: 2009

Journal Articles

NK Cell-Mediated Rejection of Bone Marrow Cells- In Vivo Evidence of NK Cell Subset Licensing.

Kai Sun, MD, Isabel Barao, PhD, Doug Redelman, PhD, William Murphy, PhD

Blood (2009) 114 (22): 3537.

https://doi.org/10.1182/blood.V114.22.3537.3537

Published: 2009

Journal Articles

Critical and Opposing Effects of T Cell-Derived TNFα and Interferon-γ on IL-17 Induction Assessed in Vitro and in Vivo Following Allogeneic Bone Marrow Transplantation

Minghui Li, Kai Sun, Mark Hubbard, Doug Redelman, Angela Panoskaltsis-Mortari, Sergei Nedospasov, Dennis Taub, Bruce Blazar, Lisbeth A. Welniak, William J. Murphy

Blood (2008) 112 (11): 3482.

https://doi.org/10.1182/blood.V112.11.3482.3482

Published: 2008

Journal Articles

In Vivo Development of Murine NK Cells Early after Congeneic BMT: Effects of MHC Molecules, and the Administration of hIL-15.

Isabel Barao-Silvestre, PhD, Doug Redelman, PhD, Erik Ames, Jonathan Weiss, PhD, Kai Sun, PhD, Lisbeth Welniak, PhD, John Ortaldo, PhD, Robert Wiltrout, PhD, William Murphy, PhD

Blood (2008) 112 (11): 2334.

https://doi.org/10.1182/blood.V112.11.2334.2334

Published: 2008

NARROW

Delineation of antigen-specific and antigen-nonspecific CD8 + memory T-cell responses after cytokine-based cancer immunotherapy

Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing

Mouse Ly49G2 + NK cells dominate early responses during both immune reconstitution and activation independently of MHC

Natural Killer (NK) Cell Recovery After Bone Marrow Transplantation in Mice: Early Emergence of a Novel Ly49+ Stage in Differentiation Independent of MHC Haplotype.

NK Cell-Mediated Rejection of Bone Marrow Cells- In Vivo Evidence of NK Cell Subset Licensing.

Critical and Opposing Effects of T Cell-Derived TNFα and Interferon-γ on IL-17 Induction Assessed in Vitro and in Vivo Following Allogeneic Bone Marrow Transplantation

In Vivo Development of Murine NK Cells Early after Congeneic BMT: Effects of MHC Molecules, and the Administration of hIL-15.

Email alerts

ASH Publications

American Society of Hematology

Delineation of antigen-specific and antigen-nonspecific CD8 + memory T-cell responses after cytokine-based cancer immunotherapy

Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing

Mouse Ly49G2 + NK cells dominate early responses during both immune reconstitution and activation independently of MHC

Natural Killer (NK) Cell Recovery After Bone Marrow Transplantation in Mice: Early Emergence of a Novel Ly49+ Stage in Differentiation Independent of MHC Haplotype.

NK Cell-Mediated Rejection of Bone Marrow Cells- In Vivo Evidence of NK Cell Subset Licensing.

Critical and Opposing Effects of T Cell-Derived TNFα and Interferon-γ on IL-17 Induction Assessed in Vitro and in Vivo Following Allogeneic Bone Marrow Transplantation

In Vivo Development of Murine NK Cells Early after Congeneic BMT: Effects of MHC Molecules, and the Administration of hIL-15.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only